Post date July 28, 2023 Experience BMS $35 million investment in Immatics We advised Immatics on the private placement of ordinary shares
Post date July 18, 2023 Experience Korro Bio $117 million private placement The financing is expected to close immediately prior to the completion of Korro Bio’s merger with Frequency Therapeutics
Post date June 8, 2023 Experience Samarco Mineração enters into restructuring support agreement We are advising an ad hoc group in connection with the restructuring
Post date May 24, 2023 Experience XPO $1.28 billion senior notes offerings The senior notes are due 2028 and 2031
Post date May 18, 2023 Experience Emergent BioSolutions $150 million at-the-market offering The shares are listed on the NYSE
Post date May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction
Post date April 14, 2023 Experience InflaRx follow-on offering The shares are listed on the Nasdaq Global Market
Post date March 16, 2023 Experience Ormat Technologies $297 million follow-on offering The stock is listed on the NYSE and Tel Aviv Stock Exchange
Post date March 6, 2023 Experience Alteryx $450 million senior notes offering The 8.75% notes are due 2028
Post date March 6, 2023 Experience Stanley Black & Decker $750 million notes offering The investment-grade notes are due 2026 and 2028